000 | 01134 a2200265 4500 | ||
---|---|---|---|
005 | 20250513195736.0 | ||
264 | 0 | _c19991214 | |
008 | 199912s 0 0 eng d | ||
022 | _a1081-1206 | ||
024 | 7 |
_a10.1016/S1081-1206(10)62844-X _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorris, D L | |
245 | 0 | 0 |
_aWHO position paper on oral (sublingual) immunotherapy. _h[electronic resource] |
260 |
_bAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology _cNov 1999 |
||
300 |
_a423-4 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdministration, Sublingual |
650 | 0 | 4 |
_aAllergens _xadministration & dosage |
650 | 0 | 4 | _aDesensitization, Immunologic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRespiratory Hypersensitivity _xtherapy |
650 | 0 | 4 | _aWorld Health Organization |
773 | 0 |
_tAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology _gvol. 83 _gno. 5 _gp. 423-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1081-1206(10)62844-X _zAvailable from publisher's website |
999 |
_c10538918 _d10538918 |